Last reviewed · How we verify
Antihypertensive algorithm
An algorithmic treatment protocol that guides sequential selection and titration of antihypertensive medications to achieve blood pressure control.
An algorithmic treatment protocol that guides sequential selection and titration of antihypertensive medications to achieve blood pressure control. Used for Hypertension management and blood pressure control.
At a glance
| Generic name | Antihypertensive algorithm |
|---|---|
| Sponsor | University Hospital, Tours |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
This is a clinical decision-support algorithm rather than a single drug entity. It systematizes the stepwise initiation and optimization of antihypertensive agents based on patient characteristics, comorbidities, and blood pressure response. The algorithm approach aims to standardize treatment escalation and improve adherence to guideline-directed medical therapy for hypertension management.
Approved indications
- Hypertension management and blood pressure control
Common side effects
Key clinical trials
- Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women
- REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription (NA)
- Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial (NA)
- A Study of Blood Pressure Control During Cancer Treatment (PHASE2)
- Preventing Cognitive Decline by Reducing BP Target Trial (NA)
- Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease (PHASE3)
- Project 2: ACHIEVE- HF (NA)
- Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antihypertensive algorithm CI brief — competitive landscape report
- Antihypertensive algorithm updates RSS · CI watch RSS
- University Hospital, Tours portfolio CI